Cognetivity Neurosciences Ltd. Share Price

Stocks

CGNSF

CA19243C1005

Advanced Medical Equipment & Technology

OTC Markets Traded
Market Closed - 16:36:14 02/11/2026 GMT 5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Cognetivity Neurosciences Ltd. 0.00% -

Valuation: Cognetivity Neurosciences Ltd.

Market Cap 1.2M 835K 762K 702K 639K 77.43M 1.26M 8.54M 3.39M 42.23M 3.14M 3.07M 132M P/E 2022
-2.9x
P/E 2023 -2.8x
Enterprise Value 245K 171K 156K 144K 131K 15.84M 259K 1.75M 693K 8.64M 641K 628K 27.1M EV / Sales 2022
-
EV / Sales 2023 437,922,999x
Free-Float
85.56%
Yield 2022 *
-
Yield 2023 -
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.07
5 years 0
Extreme 1.0E-6
0.52
10 years 0
Extreme 1.0E-6
1.12
Manager TitleAgeSince
Chief Executive Officer 45 31/03/2013
Compliance Officer 67 20/12/2017
Director TitleAgeSince
Director/Board Member 45 31/12/2016
Director/Board Member 67 20/12/2017
Date Insider Type Main position Quantity % Market Cap. Importance
15/04/24 Option

Founder

600,000 0.6697%
15/04/24 Option

Founder

600,000 0.6697%
23/06/23 Sell

Founder

1,108,160 1.3030%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 93
-2.79%-4.38%+16.90%+42.75% 248B
-3.16%-5.43%-0.82%+4.42% 155B
-2.01%-10.04%-27.74%+28.17% 138B
-2.35%-5.32%-56.54%-22.92% 60.85B
-1.95%-4.95%+21.12%+51.59% 58.56B
-1.96%-2.25%+4.04%-14.08% 52.46B
-2.83%-2.06%+17.45%+49.48% 48.04B
-3.51%-4.30%+16.33%+68.80% 43.29B
+1.26%-11.71%-1.58%+48.97% 43.1B
Average -1.93%-3.79%-1.20%+28.58% 85B
Weighted average by Cap. -2.42%-3.87%-0.34%+27.77%

Financials

2022 2023
Net sales - 0.05 0.03 0.03 0.03 0.02 2.93 0.05 0.32 0.13 1.6 0.12 0.12 5.01
Net income -13.13M -9.15M -8.35M -7.69M -7M -848M -13.85M -93.54M -37.12M -463M -34.34M -33.62M -1.45B -7.43M -5.18M -4.73M -4.35M -3.96M -480M -7.84M -52.97M -21.02M -262M -19.45M -19.04M -822M
Net Debt -82.43K -57.43K -52.41K -48.27K -43.94K -5.33M -86.95K -587K -233K -2.9M -216K -211K -9.11M -953K -664K -606K -558K -508K -61.59M -1.01M -6.79M -2.7M -33.59M -2.49M -2.44M -105M
Logo Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
Employees
-
  1. Stock Market
  2. Stocks
  3. CGNSF Stock